Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds
Within one year, 46.5% of patients with type 2 diabetes and 64.8% without type 2 diabetes discontinued GLP-1 RA therapy.
KRDO11d
VA to end cross-sex hormone therapy for transgender veterans
The U.S. Department of Veterans Affairs (VA) says they will stop offering "cross-sex hormone therapy" for transgender ...
EurekAlert!1mon
Gene therapy may be “one shot stop” for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.